Discovery - University of Dundee - Online Publications

Library & Learning Centre

Prednisolone or acyclovir in Bell's palsy - Reply

Standard

Prednisolone or acyclovir in Bell's palsy - Reply. / Sullivan, Frank; Swan, Iain; Daly, Fergus.

In: New England Journal of Medicine, Vol. 358, No. 3, 17.01.2008, p. 307-307.

Research output: Contribution to journal › Letter

Harvard

Sullivan, F, Swan, I & Daly, F 2008, 'Prednisolone or acyclovir in Bell's palsy - Reply' New England Journal of Medicine, vol 358, no. 3, pp. 307-307.

APA

Sullivan, F., Swan, I., & Daly, F. (2008). Prednisolone or acyclovir in Bell's palsy - Reply. New England Journal of Medicine, 358(3), 307-307

Vancouver

Sullivan F, Swan I, Daly F. Prednisolone or acyclovir in Bell's palsy - Reply. New England Journal of Medicine. 2008 Jan 17;358(3):307-307.

Author

Sullivan, Frank; Swan, Iain; Daly, Fergus / Prednisolone or acyclovir in Bell's palsy - Reply.

In: New England Journal of Medicine, Vol. 358, No. 3, 17.01.2008, p. 307-307.

Research output: Contribution to journal › Letter

Bibtex - Download

@article{53716a2e3b0b4579b8b2be1294531bba,
title = "Prednisolone or acyclovir in Bell's palsy - Reply",
author = "Frank Sullivan and Iain Swan and Fergus Daly",
year = "2008",
volume = "358",
number = "3",
pages = "307--307",
journal = "New England Journal of Medicine",
issn = "0028-4793",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Prednisolone or acyclovir in Bell's palsy - Reply

A1 - Sullivan,Frank

A1 - Swan,Iain

A1 - Daly,Fergus

AU - Sullivan,Frank

AU - Swan,Iain

AU - Daly,Fergus

PY - 2008/1/17

Y1 - 2008/1/17

M1 - Letter

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 3

VL - 358

SP - 307

EP - 307

ER -

Documents

Handle.net

From the same journal

  • Tiotropium in asthma

    Lipworth, B., Manoharan, A. & Short, P. 27-Dec-2012 In : New England Journal of Medicine. 367, 26, p. 2552, 1 p.

    Research output: Contribution to journal › Letter

  • Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

    Howard, R. , McShane, R. , Lindesay, J. , Ritchie, C. , Baldwin, A. , Barber, R. , Burns, A. , Dening, T. , Findlay, D. , Holmes, C. , Hughes, A. , Jacoby, R. , Jones, R. , Jones, R. , McKeith, I. , Macharouthu, A. , O'Brien, J. , Passmore, P. , Sheehan, B. , Juszczak, E. & 13 others Katona, C., Hills, R., Knapp, M., Ballard, C., Brown, R., Banerjee, S., Onions, C., Griffin, M., Adams, J., Gray, R., Johnson, T., Bentham, P. & Phillips, P. 8-Mar-2012 In : New England Journal of Medicine. 366, 10, p. 893-903, 11 p.

    Research output: Contribution to journal › Article

  • Alopecia areata

    Dawe, R. S. 2012 In : New England Journal of Medicine. 367, 3, p. 279-280, 2 p.

    Research output: Contribution to journal › Letter

  • Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

    Papaemmanuil, E. , Cazzola, M. , Boultwood, J. , Malcovati, L. , Vyas, P. , Bowen, D. , Pellagatti, A. , Wainscoat, J. S. , Hellstrom-Lindberg, E. , Gambacorti-Passerini, C. , Godfrey, A. L. , Rapado, I. , Cvejic, A. , Rance, R. , McGee, C. , Ellis, P. , Mudie, L. J. , Stephens, P. J. , McLaren, S. , Massie, C. E. & 29 others Tarpey, P. S., Varela, I., Nik-Zainal, S., Davies, H. R., Shlien, A., Jones, D., Raine, K., Hinton, J., Butler, A. P., Teague, J. W., Baxter, E. J., Score, J., Galli, A., Della Porta, M. G., Travaglino, E., Groves, M., Tauro, S., Munshi, N. C., Anderson, K. C., El-Naggar, A., Fischer, A., Mustonen, V., Warren, A. J., Cross, N. C. P., Green, A. R., Futreal, P. A., Stratton, M. R., Campbell, P. J. & Int Canc Genome Consortium 13-Oct-2011 In : New England Journal of Medicine. 365, 15, p. 1384-1395, 12 p.

    Research output: Contribution to journal › Article

  • Filaggrin mutations associated with skin and allergic diseases

    Irvine, A. D., McLean, W. H. I. & Leung, D. Y. M. 6-Oct-2011 In : New England Journal of Medicine. 365, 14, p. 1315-1327, 13 p.

    Research output: Contribution to journal › Article

Library & Learning Centre

Contact | Accessibility | Policy